These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
597 related articles for article (PubMed ID: 27221849)
1. Uterine Sarcoma: Clinical Presentation, Treatment and Survival Outcomes in Thailand. Potikul C; Tangjitgamol S; Khunnarong J; Srijaipracharoen S; Thavaramara T; Pataradool K Asian Pac J Cancer Prev; 2016; 17(4):1759-67. PubMed ID: 27221849 [TBL] [Abstract][Full Text] [Related]
2. The Impact of Adjuvant Therapy on Survival and Recurrence Patterns in Women With Early-Stage Uterine Carcinosarcoma: A Multi-institutional Study. Guttmann DM; Li H; Sevak P; Grover S; Jacobson G; Feldman A; Rubin S; Chu C; Bhatia S; Elshaikh MA; Lin LL Int J Gynecol Cancer; 2016 Jan; 26(1):141-8. PubMed ID: 26509850 [TBL] [Abstract][Full Text] [Related]
3. The influence of primary site on outcomes in leiomyosarcoma: a review of clinicopathologic differences between uterine and extrauterine disease. Farid M; Ong WS; Tan MH; Foo LS; Lim YK; Chia WK; Soh LT; Poon D; Lee MJ; Ho ZC; Jeevan R; Chin F; Teo M; Quek R Am J Clin Oncol; 2013 Aug; 36(4):368-74. PubMed ID: 22772425 [TBL] [Abstract][Full Text] [Related]
4. Uterine sarcoma: clinicopathological characteristics, treatment and outcome in Iran. Ghaemmaghami F; Karimi-Zarchi M; Gilani MM; Mousavi A; Behtash N; Ghasemi M Asian Pac J Cancer Prev; 2008; 9(3):421-6. PubMed ID: 18990014 [TBL] [Abstract][Full Text] [Related]
5. Uterine sarcoma-current management and experience from a regional cancer centre in North India. Biswas A; Patel F; Kumar P; Srinivasan R; Bera A; Sharma SC; Rajwanshi A Arch Gynecol Obstet; 2013 Oct; 288(4):873-82. PubMed ID: 23580012 [TBL] [Abstract][Full Text] [Related]
6. Prognostic factors and treatment outcomes in 93 patients with uterine sarcoma from 4 centers in Turkey. Durnali A; Tokluoğlu S; Özdemir N; Inanç M; Alkiş N; Zengin N; Sönmez ÖU; Küçüköner M; Asian Pac J Cancer Prev; 2012; 13(5):1935-41. PubMed ID: 22901150 [TBL] [Abstract][Full Text] [Related]
7. [Postoperative radiotherapy of uterine sarcoma: a multicentric retrospective study]. Champetier C; Hannoun-Levi JM; Resbeut M; Azria D; Salem N; Tessier E; Ellis S; Cowen D; Cancer Radiother; 2011 Apr; 15(2):89-96. PubMed ID: 20674447 [TBL] [Abstract][Full Text] [Related]
8. Clinical outcomes of uterine carcinosarcoma: results of 94 patients. Gokce ZK; Turan T; Karalok A; Tasci T; Ureyen I; Ozkaya E; Kose MF; Tulunay G Int J Gynecol Cancer; 2015 Feb; 25(2):279-87. PubMed ID: 25611900 [TBL] [Abstract][Full Text] [Related]
9. [Clinicopathologic characteristics and prognosis factors of uterine sarcomas in central Tunisia]. Khlifi A; Fathallah K; Zbidi C; Hidar S; Bibi M; Khairi H Bull Cancer; 2014; 101(7-8):669-80. PubMed ID: 25091649 [TBL] [Abstract][Full Text] [Related]
10. Tumor characteristics and outcome of uterine carcinosarcoma in women aged ≥80 years. Matsuo K; Ross MS; Yunokawa M; Johnson MS; Machida H; Omatsu K; Klobocista MM; Im DD; Satoh S; Baba T; Ikeda Y; Bush SH; Hasegawa K; Blake EA; Takekuma M; Shida M; Nishimura M; Adachi S; Pejovic T; Takeuchi S; Yokoyama T; Ueda Y; Iwasaki K; Miyake TM; Yanai S; Nagano T; Takano T; Shahzad MM; Ueland FR; Kelley JL; Roman LD Surg Oncol; 2019 Jun; 29():25-32. PubMed ID: 31196490 [TBL] [Abstract][Full Text] [Related]
11. Comparison of current staging systems and a novel staging system for uterine leiomyosarcoma. Giuntoli RL; Lessard-Anderson CR; Gerardi MA; Kushnir CL; Cliby WA; Metzinger DS; Gostout BS Int J Gynecol Cancer; 2013 Jun; 23(5):869-76. PubMed ID: 23669444 [TBL] [Abstract][Full Text] [Related]
12. Uterine adenosarcoma with sarcomatous overgrowth versus uterine carcinosarcoma: comparison of treatment and survival. Krivak TC; Seidman JD; McBroom JW; MacKoul PJ; Aye LM; Rose GS Gynecol Oncol; 2001 Oct; 83(1):89-94. PubMed ID: 11585418 [TBL] [Abstract][Full Text] [Related]
13. Long-term outcomes with intraoperative radiotherapy as a component of treatment for locally advanced or recurrent uterine sarcoma. Barney BM; Petersen IA; Dowdy SC; Bakkum-Gamez JN; Haddock MG Int J Radiat Oncol Biol Phys; 2012 May; 83(1):191-7. PubMed ID: 21985942 [TBL] [Abstract][Full Text] [Related]
14. Uterine sarcoma. Clinico-pathological characteristics and outcome. Sait HK; Anfinan NM; El Sayed ME; Alkhayyat SS; Ghanem AT; Abayazid RM; Sait KH Saudi Med J; 2014 Oct; 35(10):1215-22. PubMed ID: 25316466 [TBL] [Abstract][Full Text] [Related]
15. Impact of adjuvant therapy on recurrence patterns in stage I uterine carcinosarcoma. Matsuo K; Omatsu K; Ross MS; Johnson MS; Yunokawa M; Klobocista MM; Im DD; Bush SH; Ueda Y; Takano T; Blake EA; Hasegawa K; Baba T; Shida M; Satoh S; Yokoyama T; Machida H; Adachi S; Ikeda Y; Iwasaki K; Miyake TM; Yanai S; Nishimura M; Nagano T; Takekuma M; Takeuchi S; Pejovic T; Shahzad MM; Ueland FR; Kelley JL; Roman LD Gynecol Oncol; 2017 Apr; 145(1):78-87. PubMed ID: 28215838 [TBL] [Abstract][Full Text] [Related]
16. Sarcoma of the prostate: a single institutional review. Janet NL; May AW; Akins RS Am J Clin Oncol; 2009 Feb; 32(1):27-9. PubMed ID: 19194120 [TBL] [Abstract][Full Text] [Related]
18. State of the science: Uterine sarcomas: From pathology to practice. Shushkevich A; Thaker PH; Littell RD; Shah NA; Chiang S; Thornton K; Hensley ML; Slomovitz BM; Holcomb KM; Leitao MM; Toboni MD; Powell MA; Levine DA; Dowdy SC; Klopp A; Brown J Gynecol Oncol; 2020 Oct; 159(1):3-7. PubMed ID: 32839026 [No Abstract] [Full Text] [Related]
19. Uterine carcinosarcoma and high-risk endometrial carcinomas: a clinicopathological comparison. Zhang C; Hu W; Jia N; Li Q; Hua K; Tao X; Wang L; Feng W Int J Gynecol Cancer; 2015 May; 25(4):629-36. PubMed ID: 25633654 [TBL] [Abstract][Full Text] [Related]
20. Stage I uterine carcinosarcoma: Matched cohort analyses for lymphadenectomy, chemotherapy, and brachytherapy. Seagle BL; Kanis M; Kocherginsky M; Strauss JB; Shahabi S Gynecol Oncol; 2017 Apr; 145(1):71-77. PubMed ID: 28317560 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]